Skip to content

The benefit of ultra-high resolution computed tomography: Precision of repeated volume measurements of pulmonary nodules

The benefit of ultra-high resolution computed tomography: Precision of repeated volume measurements of pulmonary nodules - Coffee Break

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45824
Enrollment
80
Registered
2019-02-25
Start date
2019-05-28
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Mestastase - Lung cancer

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * 18 years of age or older * A solid primary tumour anywhere in the body and solid, noncalcified nodules in the pulmonary parenchyma on previous CT scans suspected for pulmonary metastases, according to radiological reports * Two lung nodules that do not abut vessels or pleura with a two dimensional diameter between 5 and 10 mm within a distance of each other of 16 cm in the craniocaudal direction

Exclusion criteria

Exclusion criteria: * Immobility (not able to stand up and get off the scanner table) * Patients who received local pulmonary treatment: o Radiotherapy o Excision o Ablation * Patients with radiologically suspected lymphangitis carcinomatosa or consolidations around the nodules. * Patients who only have calcified pulmonary nodules or nodules that about vessels or pleura.

Design outcomes

Primary

MeasureTime frame
The main endpoint of this study is the upper limit of the 95% confidence interval of repeated semi-automated nodule volume measurements of both CT scanners.

Secondary

MeasureTime frame
* To assess the variability in manual calliper two-dimensional measurements of pulmonary nodules. * To assess the effect of subjective image quality, structure delineation and segmentation, and nodule type on the variability in volume of the nodule measurements.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)